Merck Millipore and Singulex, the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, have announced that they have entered into a definitive
Company terminates existing sales agreement with BlueWave Healthcare Consultants Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today outlined
Singulex, Inc., the leading provider of Single Molecule Counting (SMC™) technology for scientific discovery and clinical testing services, today announced it has secured a debt facility for up to $40
